Miniatura

Fitxers

706960.pdf (533.9 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2020-10-19

Llicència de publicació

cc-by (c) Martínez López, Joaquín et al., 2020
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/174017

Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1038/s41408-020-00372-5

Resum

There is limited information on the characteristics, prognostic factors, and outcomes of patients with multiplemyeloma (MM) hospitalized with COVID-19. This retrospective case series investigated 167 patients reported from 73hospitals within the Spanish Myeloma Collaborative Group network in March and April, 2020. Outcomes werecompared with 167 randomly selected, contemporary, age-/sex-matched noncancer patients with COVID-19 admittedat six participating hospitals. Among MM and noncancer patients, median age was 71 years, and 57% of patients weremale; 75 and 77% of patients, respectively, had at least one comorbidity. COVID-19 clinical severity wasmoderate-severe in 77 and 89% of patients and critical in 8 and 4%, respectively. Supplemental oxygen was requiredby 47 and 55% of MM and noncancer patients, respectively, and 21%/9% vs 8%/6% required noninvasive/invasiveventilation. Inpatient mortality was 34 and 23% in MM and noncancer patients, respectively. Among MM patients,inpatient mortality was 41% in males, 42% in patients aged >65 years, 49% in patients with active/progressive MM athospitalization, and 59% in patients with comorbid renal disease at hospitalization, which were independentprognostic factors on adjusted multivariate analysis. This case series demonstrates the increased risk and identifiespredictors of inpatient mortality among MM patients hospitalized with COVID-19.

Matèries

COVID-19, Pronòstic mèdic, Mieloma múltiple

Matèries (anglès)

COVID-19, Prognosis, Multiple myeloma

Citació

Col·leccions

Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

MARTÍNEZ LÓPEZ, Joaquín, MATEOS, María victoria, ENCINAS, Cristina, SUREDA, Anna, HERNÁNDEZ RIVAS, José ángel, LÓPEZ DE LA GUÍA, Ana, CONDE, Diego, KRSNIK, Isabel, PRIETO, Elena, RIAZA GRAU, Rosalía, GIRONELLA, Mercedes, BLANCHARD, María jesús, CAMINOS, Nerea, FERNÁNDEZ DE LARREA RODRÍGUEZ, Carlos josé, SENÍN, Alicia, ESCALANTE, Fernando, PUERTA, José enrique de la, GIMÉNEZ, Eugenio, MARTÍNEZ BARRANCO, Pilar, MATEOS, Juan josé, CASADO, Luis felipe, BLADÉ, J. (joan), LAHUERTA, Juan josé, SAN MIGUEL, Jesús. Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality. _Blood Cancer Journal_. 2020. Vol. 10, núm. 103. [consulta: 25 de febrer de 2026]. ISSN: 2044-5385. [Disponible a: https://hdl.handle.net/2445/174017]

Exportar metadades

JSON - METS

Compartir registre